Vitalibis, Inc.

VCBD

US92849U1051

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 11:01:49 24/05/2024 pm IST			5-day change	1st Jan Change
0.0001 ^USD	-.--%		-.--%	-50.00%

2021	Vitalibis, Inc. Bankruptcy Case Dismissed	CI
2021	Motion for Case Dismissal Filed for Vitalibis, Inc.	CI

Sheng Ying Entertainment Corp. Announces Executive Changes

December 14, 2017 at 03:45 am IST

Sheng Ying Entertainment Corp. announced appointment of Markus W. Frick as a Director, to fill the remaining term of Mr. Siew Heok Ong, who resigned October 24, 2017.

Latest news about Vitalibis, Inc.

Vitalibis, Inc. Bankruptcy Case Dismissed	02/21/02	CI
Motion for Case Dismissal Filed for Vitalibis, Inc.	02/21/02	CI
Disclosure Statement Conditionally Approved for Vitalibis, Inc.	19/20/19	CI
Reorganization Plan and Disclosure Statement Filed by Vitalibis, Inc.	18/20/18	CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	17/20/17	CI
Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2020	14/20/14	CI
Vitalibis, Inc. Filed for Bankruptcy	15/20/15	CI
Vitalibis, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2020	15/20/15	CI
Vitalibis, Inc. Alliance with Bruce Lee Beverage by Offering Actual Being™ Focus Adaptogen + Superfood Herbal Supplement	01/20/01	CI
Vitalibis, Inc. Reports Earnings Results for the Full Year Ended December 31, 2019	14/20/14	CI
Vitalibis, Inc. Auditor Raises 'Going Concern' Doubt	13/20/13	CI
Vitalibis, Inc. Launches CBD+ Skincare Product Line	28/20/28	CI
Vitalibis and OakLeaf Wellness + Health Announce National Alliance to Distribute Full-Spectrum CBD Wellness Products	12/19/12	CI
Vitalibis, Inc. and Stylevate Completes Technology Integration Using Proprietary Peer-to-Peer Engagement SaaS Platform In Fashion Industry	19/19/19	CI
Vitalibis, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	09/19/09	CI
Vitalibis, Inc. Announces Business Alliance with Natural Recovery Greens	17/19/17	CI
Vitalibis and Living Beyond Breast Cancer Form Business Alliance Dedicated to Providing Education, Programs and Services for Those Impacted by Breast Cancer	10/19/10	CI
Vitalibis, Inc. Announces Appointment of Dave Harper to the Advisory Board	25/19/25	CI
Vitalibis, Inc. Announces Premium Water Soluble Hemp Powder Supply Agreement with UbU Beverages	17/19/17	CI
Vitalibis, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	10/19/10	CI
Vitalibis Launches Signature AB900 Hemp Oil with Naturally Occurring CBD in Collaboration with the Bruce Lee Family	26/19/26	CI
Vitalibis, Inc. Appoints Steven Zodkoy as Founding Member of Scientific Advisory Board	17/19/17	CI
Vitalibis, Inc. Announces Unaudited Earnings Results for the First Quarter Ended March 31, 2019	13/19/13	CI
Vitalibis Launches New Signature 600 Premium CBD Hemp Oil	15/19/15	CI
Vitalibis, Inc. Appoints Dusty Baker to Advisory Board	02/19/02	CI

Vitalibis, Inc. is a socially conscious brand focused on people, products and the planet. The Company is a technology-based formulator of premium, full spectrum Phyto cannabinoid rich hemp products with naturally occurring cannabidiol, along with safe personal care and nutritional products. The Companyâs Ambassador program combines the elements of social selling, ecommerce and affiliate marketing into one program empowering its people and social mission driven ecosystem.

Sector

Pharmaceuticals

More about the company

Sector Other Pharmaceuticals

	1st Jan change	Capi.
VITALIBIS, INC.	-50.00%	34.59K
ELI LILLY AND COMPANY	+55.32%	815B
NOVO NORDISK A/S	+44.05%	641B
JOHNSON & JOHNSON	-6.75%	352B
MERCK & CO., INC.	+13.56%	314B
ABBVIE INC.	+10.68%	303B
ASTRAZENECA PLC	+16.57%	242B
ROCHE HOLDING AG	+2.04%	224B
NOVARTIS AG	+13.31%	218B
AMGEN INC.	+8.48%	168B

Other Pharmaceuticals

Vitalibis, Inc.

Equities

VCBD

US92849U1051

Pharmaceuticals

Sheng Ying Entertainment Corp. Announces Executive Changes

Latest news about Vitalibis, Inc.

Chart Vitalibis, Inc.

Company Profile

Sector Other Pharmaceuticals